Old and new antidepressants: Where are we?

World Journal of Biological Psychiatry

Volumn 3, Issue 3, 2002, Pages 112-114

  Ayuso Gutiérrez, José Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

EDITORIAL; HUMAN; MAJOR DEPRESSION;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; HUMANS; MONOAMINE OXIDASE INHIBITORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0036636793     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970209150611     Document Type: Editorial

References (17)

1. Amsterdam JD, Honig-Rohan M (1996) Treatment algorithms in treatment-resistant depression. Psychiatric Clinics of North America 19:371-385.
2. Anderson IM (1998) SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety 7(Suppl 1):11-17.
3. Chen LS, Eaton WW, Gallo JJ, Nestadt G (2000) Understanding the heterogeneity of depression through the triad of symptoms, course and risk factors. A longitudinal, population-based study. J Affect Disord 59:1-11.
4. Clerc GE, Ruimy P, Verdeau-Palles J (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Int Clin Psychopharmacol 9:139-143.
5. Danish University Antidepressant Group (1986) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 90:131-138.
6. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 18:289-299.
7. Demyttenaere K, Van Ganse E, Gregoire J, Gaens E, Mesters P (1998) Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. Int Clin Psychopharmacol 13:11-17.
8. Donoghue J (2000) Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand 403:57-61.
9. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:607-608.
10. Ferrier IN (1999) Treatment of major depression: is improvement enough? J Clin Psychiatry 60:10-14.
11. Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J (2000) SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev 2: CD001851.
12. Hirschfeld RM (2001) Clinical importance of long-term antidepressant treatment. Br J Psychiatry 42(Suppl):S4-S8.
13. Parker G, Mitchell P, Wilhelm K, Menkes D, Snowdon J, Schweitzer I, Grounds D, Skerritt P, Roy K, Hadzi-Pavlovic D (1999) Are the newer antidepressant drugs as effective as established physical treatment? Aust N Z Psychiatry 33:874-881.
14. Petersen T, Dording C, Neault NB, Kombluh R, Alpert JE, Nierenberg AA, Rosembaum JF (2002) A survey of prescribing practices in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 26:177-187.
15. Salomon RM, Miller HL, Krystal JH, Heninger GR, Charney DS (1997) Lack of behavioral effects of monoamine depletion in healthy subjects. Biol Psychiatry 41:58-64.
16. Tzanakaki M, Guazzelli M, Nimatoudis I, Zissis NP, Smeraldi E, Rizzo F (2000) Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. Int Clin Psychopharmacol 15:29-34.
17. von Frenckell R, Ansseau M, Serre C, Sutet P (1990) Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies. Int Clin Psychopharmacol 5:49-56.